D2 vs D3 Lymph Node Dissection for Left Colon Cancer
About this study
The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissection. Investigation of the functional and short-term outcomes will clarify safety of the D3 lymph node dissection.
- Condition
- Colon Cancer
- Tested
- Left colon resection, Sigmoid colon resection, Distal sigmoid colon resection or anterior resection
- Sponsor
- Russian Society of Colorectal Surgeons
Who can join
- Age
- 18 to 75 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 9
- Minimum age: 18 years
- Maximum age: 75 years
- Study condition: Colon Cancer
- Agreement of the patient to participate in trial
- Colon cancer (only adenocarcinoma )
- The tumor located between the splenic flexure and rectosigmoid junction
- cT3-Т4а,b
- Tolerance of chemotherapy
- ASA 1-3
Exclusion 5
- сТis - Т2, сТ4b (tail of the pancreas, stomach, small bowel, ureter, urinary bladder)
- Preoperative complications of the tumor (perforation and full bowel 3. obstruction)
- Previous radiotherapy or chemotherapy
- Synchronous or metachronous tumors
- Women during Pregnancy or breast feeding period
Where
1 site, 1 recruiting
Clinic of coloproctology and minimally invasive surgery
Moscow, Russia
Contact
-
Vladimir Balaban, Ph.D
+79889478358 balaban@kkmx.ru
-
Inna Tulina, Ph.D
+79264086672 tulina@kkmx.ru
Potential match only. Final eligibility is determined by the study team.